Could Reversal of $417M Calif. Verdict Foreshadow Doom for Talc Cases?
A judge's ruling tossing a record $417 million verdict in California last week could spell trouble for attorneys handling cases for plaintiffs in talc products liability litigation—and not just because of the massive size of the rejected award.
Your article was successfully shared with the contacts you provided.
This premium content is locked for New Jersey Law Journal subscribers only.
Subscribe now to enjoy unlimited access to New Jersey Law Journal content,
5 free articles* across the ALM Network every 30 days,
Exclusive access to other free ALM publications
And exclusive discounts on ALM events and publications.
*May exclude premium content Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to email@example.com to learn more.
Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She is based in Los Angeles.
Thomas Dickerson writes: This year, the Appellate Division, First Department sought to protect shareholder interests in “merger tax” litigation by enhancing the standards for the approval of disclosure-only class action settlements, and sought to protect employees by declining to enforce an arbitration agreement as violative of the National Labor Relations Act. But that's not all.
Peak Wellness Nutrition and Peal Wellness Biopharma, two distributors of dietary and nutritional supplements, file lawsuits against each other over similar trademarks.
Law Offices of Mark E. Salomone
2 Oliver St #608
Gary Martin Hays & Associates
235 Peachtree St NE #400
The Law Firm Of Jonathan C. Reiter
350 5th Ave
Presented by BigVoodoo
ALM Legal Publication Newsletters
Sign Up Today and Never Miss Another Story.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.